Suppr超能文献

重症监护病房应激性溃疡预防处方的充分性:一项观察性研究。

Adequacy of stress ulcer prophylaxis prescription in the intensive care unit: an observational study.

机构信息

Adult Intensive Care Unit, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.

Hospital Pharmacy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.

出版信息

Swiss Med Wkly. 2020 Aug 24;150:w20322. doi: 10.4414/smw.2020.20322.

Abstract

PURPOSE

Stress ulcer prophylaxis prescriptions might not be sufficiently challenged throughout a patient's stay in an intensive care unit (ICU) and might be erroneously maintained after ICU discharge. This study aimed to determine (1) stress ulcer prophylaxis adequacy in ICU and (2) the proportion of patients receiving inappropriate stress ulcer prophylaxis after ICU discharge.

MATERIAL AND METHODS

This was an observational, single centre study (University Hospital Lausanne, Switzerland). All patients without a previous indication for acid-suppressive therapy and admitted to our ICU for >24 hrs during a two-month period were included. The adequacy of stress ulcer prophylaxis prescriptions according to our guidelines was assessed. We then assessed stress ulcer prophylaxis prescriptions and their adequacy on ICU and hospital discharge, as well as the costs associated with inadequate prescription.

RESULTS

Of the 372 patients admitted during the study period, 140 (855 patient-days) fulfilled the inclusion criteria. Of these, 130 (92.9%) received stress ulcer prophylaxis in the ICU (796 [93.1%] patient-days). Stress ulcer prophylaxis consisted of esomeprazole in 686 (86.2%) patient-days. Overall, stress ulcer prophylaxis was inadequate in 558 (65.3%) patient-days, mostly because it was prescribed while not indicated (543 patient-days [63.5%]). On ICU discharge, stress ulcer prophylaxis prescription was inadequately maintained in 55 patients (51.9% of survivors). Similarly, stress ulcer prophylaxis was inadequately maintained on hospital discharge in 30 (28% of survivors) patients. We estimated the in-hospital cost of inadequate stress ulcer prophylaxis prescription as approximately CHF 2870 per year. Outpatient therapy maintenance would be associated with additional costs ranging from CHF 33,912 to 92,692 (EUR 31,832 to 87,012) for each additional year they receive the therapy, depending on the medication used.

CONCLUSIONS

The adequacy of stress ulcer prophylaxis in the ICU is low. In addition, the prescription is frequently continued after ICU and many patients are even discharged home with inadequate acid-suppressive therapy.   &nbsp.

摘要

目的

在重症监护病房(ICU)中,可能没有充分质疑应激性溃疡预防处方,并且在 ICU 出院后可能错误地维持这些处方。本研究旨在确定(1)ICU 中应激性溃疡预防的充分性,以及(2)ICU 出院后接受不适当应激性溃疡预防的患者比例。

材料和方法

这是一项观察性、单中心研究(瑞士洛桑大学医院)。在两个月的时间内,纳入了所有没有先前使用酸抑制治疗指征且在 ICU 住院时间超过 24 小时的患者。根据我们的指南评估应激性溃疡预防处方的充分性。然后,我们评估了 ICU 和出院时的应激性溃疡预防处方及其充分性,以及不适当处方相关的成本。

结果

在研究期间入院的 372 名患者中,有 140 名(855 个患者日)符合纳入标准。其中,130 名(92.9%)在 ICU 接受了应激性溃疡预防治疗(796 [93.1%] 个患者日)。应激性溃疡预防治疗包括埃索美拉唑 686 次(86.2%)。总体而言,558 个(65.3%)患者日的应激性溃疡预防治疗不充分,主要是因为处方不当(543 个患者日 [63.5%])。在 ICU 出院时,55 名(幸存者的 51.9%)患者的应激性溃疡预防处方维持不当。同样,30 名(幸存者的 28%)患者在出院时应激性溃疡预防治疗维持不当。我们估计,每年因不适当的应激性溃疡预防处方而导致的院内成本约为 2870 瑞士法郎(约合 2620 欧元)。根据所用药物的不同,对于每个额外接受治疗的患者,门诊治疗维持的额外费用将在 33912 至 92692 瑞士法郎(31832 至 87012 欧元)之间。

结论

ICU 中应激性溃疡预防的充分性较低。此外,这些处方在 ICU 后经常继续,许多患者甚至出院回家时仍未接受适当的酸抑制治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验